Drupal.behaviors.print = function(context) {window.print();window.close();}>

Quark Kidney Transplant Drug Receives FDA Orphan Drug Status

February 18, 2010

Quark Kidney Transplant Drug Receives FDA Orphan Drug Status

The designation allows for possible research and development incentives, and qualifies the company for tax credits and a period of market exclusivity following market approval.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories